Literature DB >> 27712881

Should we be following anti-factor Xa levels in patients receiving prophylactic enoxaparin perioperatively?

Christopher J Pannucci1, Matthew T Rondina2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27712881     DOI: 10.1016/j.surg.2016.07.038

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  2 in total

1.  Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin Pharmacokinetics.

Authors:  Christopher J Pannucci; Kory I Fleming; Corinne B Bertolaccini; Ann Marie Prazak; Lyen C Huang; T Bartley Pickron
Journal:  JAMA Surg       Date:  2019-08-01       Impact factor: 14.766

2.  Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study.

Authors:  Hakeam A Hakeam; Zainab Al Duhailib; Muhannad Alsemari; Reem M Alwaibah; Madhawi F Al Shannan; Munirah Shalhoub
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.